Decitabine, Cytarabine, GCSF for Refractory AML/MDS

PHASE2TerminatedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

April 30, 2010

Conditions
MyelodysplasiaLeukemia
Interventions
DRUG

chemotherapy

Trial Locations (1)

02903

Lifespan Hospitals, Providence

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Memorial Hospital of Rhode Island

OTHER

collaborator

Roger Williams Medical Center

OTHER

lead

Brown University

OTHER